|
|
|
|
|
|
|
argenx SE (ARGX)
|
|
84.905 -3.095 (-3.52%)
|
06-25 15:32
|
|
Open:
|
88.13
|
Pre. Close:
|
88
|
|
High:
|
88.13
|
Low:
|
84.48
|
|
Volume:
|
81,535
|
Market Cap:
|
2822M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
89.999 - 90.732
|
90.732 - 91.224
|
|
Low:
|
86.082 - 86.889
|
86.889 - 87.431
|
|
Close:
|
86.947 - 88.193
|
88.193 - 89.03
|
|
|
|
Technical analysis (as of: 2018-06-25 3:25:34 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 112.04  One year: 120.30
|
|
Support:
|
Support1: 84.48 Support2: 70.29
|
|
Resistance:
|
Resistance1:
95.93 Resistance2: 103.00
|
|
Pivot:
|
94.29
|
|
Moving Averages:
|
MA(5): 89.28 MA(20): 94.42
MA(100): 85.58  MA(250): 53.72
|
|
MACD:
|
MACD(12,26):
-1.03 Signal(12,26,9): 0.52
|
|
%K %D:
|
%K(14,3): 2.69 %D(3): 4.53
|
|
RSI:
|
RSI(14): 31.71
|
|
52-Week:
|
High: 103
Low: 19.36 Change(%): 306.1
|
|
Average Vol(K):
|
3-Month: 10977
10-Days 11961
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ARGX has closed below the lower band by 1.4%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 75.4% wider than normal. The large width of the bands suggest high volatility as compared to ARGX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-06-22T12:14:28-04:00
Your Daily Pharma Scoop: Reata Begins New Trial, CytoDyn Amends Protocol, Argenx Reports Positive Data
2018-06-22T08:00:00-04:00
3 Things In Biotech, June 21: Regeneron Sneaks Up In The Kidney Cancer Space
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
